Pierre Blanchet - Publications

Université de Montréal, Montréal, Canada 
Recreation, Neuroscience Biology

30 high-probability publications. We are testing a new system for linking publications to authors. You can help! If you notice any inaccuracies, please sign in and mark papers as correct or incorrect matches. If you identify any major omissions or other inaccuracies in the publication list, please let us know.

Year Citation  Score
2019 Hernandez G, Mahmoudi S, Cyr M, Diaz J, Blanchet PJ, Lévesque D. Tardive dyskinesia is associated with altered putamen Akt/GSK-3β signaling in nonhuman primates. Movement Disorders : Official Journal of the Movement Disorder Society. PMID 30675935 DOI: 10.1002/mds.27630  0.48
2017 Lévesque C, Hernandez G, Mahmoudi S, Calon F, Gasparini F, Gomez-Mancilla B, Blanchet PJ, Lévesque D. Deficient striatal adaptation in aminergic and glutamatergic neurotransmission is associated with tardive dyskinesia in non-human primates exposed to antipsychotic drugs. Neuroscience. PMID 28790021 DOI: 10.1016/j.neuroscience.2017.07.068  0.48
2016 Morand-Beaulieu S, O'Connor KP, Richard M, Sauvé G, Leclerc JB, Blanchet PJ, Lavoie ME. The Impact of a Cognitive-Behavioral Therapy on Event-Related Potentials in Patients with Tic Disorders or Body-Focused Repetitive Behaviors. Frontiers in Psychiatry. 7: 81. PMID 27242551 DOI: 10.3389/fpsyt.2016.00081  0.6
2015 Mongeon D, Blanchet P, Bergeron S, Messier J. Impact of Parkinson's disease on proprioceptively based on-line movement control. Experimental Brain Research. PMID 26055990 DOI: 10.1007/s00221-015-4343-4  0.6
2015 Morand-Beaulieu S, O'Connor KP, Sauvé G, Blanchet PJ, Lavoie ME. Cognitive-behavioral therapy induces sensorimotor and specific electrocortical changes in chronic tic and Tourette's disorder. Neuropsychologia. 79: 310-21. PMID 26022060 DOI: 10.1016/j.neuropsychologia.2015.05.024  0.6
2014 Mahmoudi S, Lévesque D, Blanchet PJ. Upregulation of dopamine D3, not D2, receptors correlates with tardive dyskinesia in a primate model. Movement Disorders : Official Journal of the Movement Disorder Society. 29: 1125-33. PMID 24838395 DOI: 10.1002/mds.25909  0.48
2014 Blanchet PJ, Rompré PH. Clinimetric evaluation of the simpson-angus scale in older adults with schizophrenia Journal of Clinical Psychopharmacology. 34: 36-39. PMID 24145218 DOI: 10.1097/JCP.0b013e3182a6a2e3  0.6
2013 Mahmoudi S, Blanchet PJ, Lévesque D. Haloperidol-induced striatal Nur77 expression in a non-human primate model of tardive dyskinesia. The European Journal of Neuroscience. 38: 2192-8. PMID 23551242 DOI: 10.1111/ejn.12198  0.48
2013 Mongeon D, Blanchet P, Messier J. Impact of Parkinson's disease and dopaminergic medication on adaptation to explicit and implicit visuomotor perturbations. Brain and Cognition. 81: 271-82. PMID 23313834 DOI: 10.1016/j.bandc.2012.12.001  0.6
2012 Blanchet PJ, Parent MT, Rompré PH, Lévesque D. Relevance of animal models to human tardive dyskinesia. Behavioral and Brain Functions : Bbf. 8: 12. PMID 22404856 DOI: 10.1186/1744-9081-8-12  0.6
2012 Girard P, Monette C, Normandeau L, Pampoulova T, Rompré PH, De Grandmont P, Blanchet PJ. Contribution of orodental status to the intensity of orofacial tardive dyskinesia: An interdisciplinary and video-based assessment Journal of Psychiatric Research. 46: 684-687. PMID 22386652 DOI: 10.1016/j.jpsychires.2012.02.003  0.6
2012 Blanchet PJ, Normandeau L, Rompré PH. Comparing three screening tools for drug-induced parkinsonism in patients with advanced schizophrenia: A pilot study Schizophrenia Research. 137: 230-233. PMID 22309978 DOI: 10.1016/j.schres.2012.01.013  0.6
2012 Blanchet PJ, Girard P, Gauthier G, Pampoulova T, Rompré PH, De Grandmont P. Dental prosthetic rehabilitation approach in tardive dyskinesia with edentulism: A case report Schizophrenia Research. 136: 162-163. PMID 21798717 DOI: 10.1016/j.schres.2011.07.004  0.6
2011 Michaud N, Al-Akoum M, Gagnon G, Girard K, Blanchet P, Rousseau JA, Akoum A. Decreased concentrations of soluble interleukin-1 receptor accessory protein levels in the peritoneal fluid of women with endometriosis. Journal of Reproductive Immunology. 92: 68-73. PMID 21958553 DOI: 10.1016/j.jri.2011.08.001  0.6
2009 Philibert M, Richer F, Blanchet PJ, Chouinard S, Dubarry AS, Fimbel E. Movement irregularities in atypical parkinsonian syndromes. Parkinsonism & Related Disorders. 15: 542-5. PMID 19103504 DOI: 10.1016/j.parkreldis.2008.11.004  0.6
2009 Tremblay PL, Bedard MA, Levesque M, Chebli M, Parent M, Courtemanche R, Blanchet PJ. Motor sequence learning in primate: role of the D2 receptor in movement chunking during consolidation. Behavioural Brain Research. 198: 231-9. PMID 19041898 DOI: 10.1016/j.bbr.2008.11.002  0.6
2009 Mongeon D, Blanchet P, Messier J. Impact of Parkinson's disease and dopaminergic medication on proprioceptive processing. Neuroscience. 158: 426-40. PMID 18996173 DOI: 10.1016/j.neuroscience.2008.10.013  0.6
2008 Blanchet PJ, Popovici R, Guitard F, Rompré PH, Lamarche C, Lavigne GJ. Pain and denture condition in edentulous orodyskinesia: comparisons with tardive dyskinesia and control subjects. Movement Disorders : Official Journal of the Movement Disorder Society. 23: 1837-42. PMID 18759358 DOI: 10.1002/mds.22102  0.6
2008 Khiat A, Kuznetsov Y, Blanchet PJ, Boulanger Y. Diffusion-weighted imaging and magnetization transfer imaging of tardive and edentulous orodyskinesia. Movement Disorders : Official Journal of the Movement Disorder Society. 23: 1281-5. PMID 18512744 DOI: 10.1002/mds.22081  0.6
2007 Kuznetsov Y, Khiat A, Blanchet PJ, Boulanger Y. Proton magnetic resonance spectroscopy study of dyskinesia patients. Movement Disorders : Official Journal of the Movement Disorder Society. 22: 957-62. PMID 17377925 DOI: 10.1002/mds.21459  0.6
2005 Blanchet PJ, Rompré PH, Lavigne GJ, Lamarche C. Oral dyskinesia: a clinical overview. The International Journal of Prosthodontics. 18: 10-9. PMID 15754887  0.6
2004 Blanchet PJ, Abdillahi O, Beauvais C, Rompré PH, Lavigne GJ. Prevalence of spontaneous oral dyskinesia in the elderly: a reappraisal. Movement Disorders : Official Journal of the Movement Disorder Society. 19: 892-6. PMID 15300653 DOI: 10.1002/mds.20130  0.6
2004 Blanchet PJ, Calon F, Morissette M, Hadj Tahar A, Bélanger N, Samadi P, Grondin R, Grégoire L, Meltzer L, Di Paolo T, Bédard PJ. Relevance of the MPTP primate model in the study of dyskinesia priming mechanisms. Parkinsonism & Related Disorders. 10: 297-304. PMID 15196509 DOI: 10.1016/j.parkreldis.2004.02.011  0.6
2004 Lemay S, Chouinard S, Blanchet P, Masson H, Soland V, Beuter A, Bédard MA. Lack of efficacy of a nicotine transdermal treatment on motor and cognitive deficits in Parkinson's disease. Progress in Neuro-Psychopharmacology & Biological Psychiatry. 28: 31-9. PMID 14687854 DOI: 10.1016/S0278-5846(03)00172-6  0.6
2004 Hadj Tahar A, Blanchet PJ, Doyon J. Motor-learning impairment by amantadine in healthy volunteers. Neuropsychopharmacology : Official Publication of the American College of Neuropsychopharmacology. 29: 187-94. PMID 14532914 DOI: 10.1038/sj.npp.1300317  0.6
2003 Lemay S, Blanchet P, Chouinard S, Masson H, Soland V, Bédard MA. Poor tolerability of a transdermal nicotine treatment in Parkinson's disease. Clinical Neuropharmacology. 26: 227-9. PMID 14520160 DOI: 10.1097/00002826-200309000-00004  0.6
2003 Blanchet PJ, Konitsiotis S, Mochizuki H, Pluta R, Emerich DF, Chase TN, Mouradian MM. Complications of a trophic xenotransplant approach in parkinsonian monkeys. Progress in Neuro-Psychopharmacology & Biological Psychiatry. 27: 607-12. PMID 12787846 DOI: 10.1016/S0278-5846(03)00048-4  0.6
2003 van den Munckhof P, Luk KC, Ste-Marie L, Montgomery J, Blanchet PJ, Sadikot AF, Drouin J. Pitx3 is required for motor activity and for survival of a subset of midbrain dopaminergic neurons. Development (Cambridge, England). 130: 2535-42. PMID 12702666 DOI: 10.1242/dev.00464  0.6
2003 Blanchet PJ, Metman LV, Chase TN. Renaissance of amantadine in the treatment of Parkinson's disease. Advances in Neurology. 91: 251-7. PMID 12442683  0.6
2002 Calon F, Morissette M, Ghribi O, Goulet M, Grondin R, Blanchet PJ, Bédard PJ, Di Paolo T. Alteration of glutamate receptors in the striatum of dyskinetic 1-methyl-4-phenyl-1,2,3,6-tetrahydropyridine-treated monkeys following dopamine agonist treatment. Progress in Neuro-Psychopharmacology & Biological Psychiatry. 26: 127-38. PMID 11853103 DOI: 10.1016/S0278-5846(01)00237-8  0.6
Show low-probability matches.